Literature DB >> 33594737

Features of humidifier lung and comparison with summer-type hypersensitivity pneumonitis.

Masafumi Shimoda1, Kozo Morimoto1, Yoshiaki Tanaka1, Koji Furuuchi1, Takeshi Osawa1, Ryozo Yano1, Hiroyuki Kokutou1, Kozo Yoshimori1, Ken Ohta1.   

Abstract

Entities:  

Year:  2021        PMID: 33594737      PMCID: PMC8048899          DOI: 10.1111/resp.14014

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


× No keyword cloud information.
Humidifier lung is a phenotype of hypersensitivity pneumonitis (HP) caused by the inhalation of humidifier vapours. A recent study comparing humidifier lung with summer‐type HP reported several distinct features, including lower serum Krebs von den Lungen‐6 (KL‐6) levels, less common centrilobular ground‐glass nodules on computed tomography scan and a higher ratio of CD4+ to CD8+ cells in bronchoalveolar lavage. However, the features and mechanisms of humidifier lung are not well characterized. Indicators for discrimination of humidifier lung from other phenotypes of HP are uncertain. Here, we report more characteristics of histopathological findings and a diagnostic predictor for humidifier lung compared to summer‐type HP, which is the most common phenotype of HP in Japan. , Among 82 adult patients hospitalized for HP at Fukujuji Hospital from April 1999 to March 2018, 7 patients with humidifier lung (18.3%) and 26 patients with summer‐type HP (43.3%) were enrolled, 22 patients with unfulfilled diagnostic criteria of HP and 27 patients with other phenotypes of HP were excluded (15 patients with various exposures to fungi contaminating a house, 4 patients with bird fancier's lung and 8 patients with unknown origin). The diagnosis of HP was based on criteria outlined in the official American Thoracic Society, Japanese Respiratory Society and Asociación Latinoamericana del Tórax (ATS/JRS/ALAT) clinical practice guideline 2020. The baseline characteristics of the patients are shown in Table 1.
Table 1

Baseline characteristics of the patients in this study

Humidifier lung (n = 7)Summer‐type HP (n = 26) P‐value
Age, median (IQR), years49.0 (43.5–53.0)56.0 (45.3–66.5)0.332
Sex (male/female)6/17/190.008
Comorbidity, n (%)3 (85.7)17 (65.4)0.397
Underlying respiratory diseases, n (%)4 (57.1)5 (19.2)0.320
Smoking history, n (%) 5 (83.3)6 (27.3)0.022
Duration from symptom onset to hospital visit, median (IQR), days 6.0 (3.0–17.5)30.0 (17.8–57.5)0.006
Symptom
Fever, n (%)7 (100)11 (42.3)0.010
Cough, n (%)3 (42.9)20 (76.9)0.161
Desaturation, n (%)4 (57.1)15 (57.7)1.000
Laboratory findings
WBC, median (IQR), cells/μL13 460 (7600‐19 350)8880 (8070–10 213)0.288
CRP, median (IQR), mg/dL5.23 (2.90–7.00)1.50 (0.60–2.98)0.027
LDH, median (IQR), IU/L § 192 (163–208)255 (218–358)0.006
KL‐6, median (IQR), U/L 316 (303–587)1690 (1093–3385)<0.001
Typical HRCT patterns of HP, n (%)4 (57.1)16 (61.5)1.000
Bronchoalveolar lavage fluid
Lymphocytes, median (IQR), %53.9 (46.5–63.4)72.5 (51.1–76.7)0.101
CD4/8 ratio, median (IQR)2.6 (1.7–4.4)0.3 (0.2–0.6)<0.001
Lung biopsy specimens ††
Granuloma, n (%)0 (0.0)9 (56.3)0.045
Alveolitis, n (%)4 (80.0)14 (87.5)1.000
Steroid therapy, n (%)3 (42.9)16 (61.5)0.442

Humidifier lung n = 6, summer‐type HP n = 22.

Humidifier lung n = 7, summer‐type HP n = 22.

Humidifier lung n = 7, summer‐type HP n = 7.

Humidifier lung n = 10, summer‐type HP n = 23.

Humidifier lung n = 5, summer‐type HP n = 16.

CD4/8 ratio, ratio of CD4+ to CD8+ cells; CRP, C‐reactive protein; HP, hypersensitivity pneumonitis; HRCT, high‐resolution computed tomography; IQR, interquartile range; KL‐6, Krebs von den Lungen‐6; LDH, lactate dehydrogenase; WBC, white blood cell.

Baseline characteristics of the patients in this study Humidifier lung n = 6, summer‐type HP n = 22. Humidifier lung n = 7, summer‐type HP n = 22. Humidifier lung n = 7, summer‐type HP n = 7. Humidifier lung n = 10, summer‐type HP n = 23. Humidifier lung n = 5, summer‐type HP n = 16. CD4/8 ratio, ratio of CD4+ to CD8+ cells; CRP, C‐reactive protein; HP, hypersensitivity pneumonitis; HRCT, high‐resolution computed tomography; IQR, interquartile range; KL‐6, Krebs von den Lungen‐6; LDH, lactate dehydrogenase; WBC, white blood cell. The humidifier lung group showed faster disease progression (shorter duration from symptom onset to hospital visit) than the summer‐type HP group (median (interquartile range (IQR)): 6.0 (3.0–17.5) vs 30.0 days (17.8–57.5), P = 0.006). Granulomas in histopathological findings were significantly less common in humidifier lung patients than in summer‐type HP patients (n = 0 (0.0%) vs n = 9 (56.3%), P = 0.045). Serum KL‐6 levels were significantly lower in humidifier lung patients than in summer‐type HP patients (median (IQR): 316 (303–587 U/mL) vs 1690 U/mL (1093–3385 U/mL), P < 0.001). The area under the receiver operating characteristic curve for serum KL‐6 for distinguishing humidifier lungs from summer‐type HP was 0.887. When the cut‐off value of serum KL‐6 was less than 674 U/mL, the sensitivity, specificity and odds ratio (OR) were 85.7%, 95.7% and 83.4 (95% CI: 5.3–5909.3), respectively. Generally, the mechanism of HP other than humidifier lung is extrinsic allergic alveolitis with type III (immune complex‐mediated) or IV (delayed) granulomas. However, antigens associated with humidifier lung have been reported in patients exposed to not only various bacteria and fungi but also endotoxins. , The mechanism of humidifier lung might be different from the other phenotypes of HP because of less frequent granuloma formation, faster disease progression and lower KL‐6 levels, as we have shown. We believe that one of the different mechanisms is related to exposure to endotoxins; however, there is no report demonstrating the presence of endotoxins in humidifier vapours. Therefore, examination of both humidifier water and vapours is warranted in future.

Key words

clinical allergy and immunology, environmental & occupational health and epidemiology, interstitial lung disease, rare lung disease.

Author contributions

Conceptualization: M.S. Data curation: M.S., Y.T., K.F., T.O., R.Y., H.K. Formal analysis: M.S. Investigation: M.S. Methodology: M.S., K.M., Y.T. Project administration: M.S., K.M., K.Y., K.O. Software: M.S. Supervision: K.M., K.Y., K.O. Validation: M.S. Visualization: M.S. Writing—original draft: M.S., K.M. Writing—review and editing: M.S., K.M., K.O.
  6 in total

1.  Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.

Authors:  Martina Vasakova; Ferran Morell; Simon Walsh; Kevin Leslie; Ganesh Raghu
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

2.  Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis.

Authors:  Susumu Sakamoto; Marie Furukawa; Hiroshige Shimizu; Muneyuki Sekiya; Shion Miyoshi; Yasuhiko Nakamura; Naohisa Urabe; Takuma Isshiki; Yusuke Usui; Kazutoshi Isobe; Yujiro Takai; Atsuko Kurosaki; Kazuma Kishi; Sakae Homma
Journal:  Respir Med       Date:  2020-10-16       Impact factor: 3.415

3.  Hypersensitivity pneumonitis associated with home ultrasonic humidifiers.

Authors:  T Suda; A Sato; M Ida; H Gemma; H Hayakawa; K Chida
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

Review 4.  Summer-type hypersensitivity pneumonitis.

Authors:  M Ando; M Suga; Y Nishiura; M Miyajima
Journal:  Intern Med       Date:  1995-08       Impact factor: 1.271

5.  Features of humidifier lung and comparison with summer-type hypersensitivity pneumonitis.

Authors:  Masafumi Shimoda; Kozo Morimoto; Yoshiaki Tanaka; Koji Furuuchi; Takeshi Osawa; Ryozo Yano; Hiroyuki Kokutou; Kozo Yoshimori; Ken Ohta
Journal:  Respirology       Date:  2021-02-16       Impact factor: 6.424

6.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

  6 in total
  2 in total

1.  Features of humidifier lung and comparison with summer-type hypersensitivity pneumonitis.

Authors:  Masafumi Shimoda; Kozo Morimoto; Yoshiaki Tanaka; Koji Furuuchi; Takeshi Osawa; Ryozo Yano; Hiroyuki Kokutou; Kozo Yoshimori; Ken Ohta
Journal:  Respirology       Date:  2021-02-16       Impact factor: 6.424

2.  Increase in humidifier lung cases owing to coronavirus disease 2019.

Authors:  Masafumi Shimoda; Kozo Morimoto; Yoshiaki Tanaka; Hiroyuki Kokutou; Takashi Uchiyama; Kozo Yoshimori; Ken Ohta
Journal:  Respir Investig       Date:  2021-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.